Progress on the Neuroscience-Based Nomenclature (NbN) for Psychotropic Medications
نویسندگان
چکیده
منابع مشابه
A Neuroscience-Based Nomenclature (NbN) for Psychotropic Agents
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact [email protected] Editorial A Neuroscience-Based N...
متن کاملNeuroscience-based Nomenclature (NbN): A call for action
The existing nomenclature for psychotropics is indication based and includes classes such as: Antidepressant, Antipsychotic, Anxiolytic, Hypnotic, Mood stabiliser, Stimulant and ‘‘Other’’. This nomenclature often leads to awkward clinical situations; we prescribe ‘‘antidepressants’’ in anxiety disorder (Klein 1964) and ‘‘antipsychotics’’ in depression and anxiety (Komossa et al. 2010; Zohar & A...
متن کاملNeuroscience-based Nomenclature (NbN) for Journal of Psychopharmacology.
As of May 2016, the Journal of Psychopharmacology will fully adopt Neuroscience-based Nomenclature (NbN) for all publications and correspondence. In this, we join many other leading journals in our field, including European Neuropsychopharmacology, Biological Psychiatry, CNS Spectrums, European Psychiatry, International Journal of Neuropsychopharmacology, Journal of Clinical Psychopharmacology,...
متن کاملUtilisation of psychotropic medications
The timely article by Verdoux & Begaud ́ hopefully begins to redress the imbalance between randomised controlled trials and other ways of evaluating drug treatments. I would like to present further evidence for the ‘gap between guidelines and utilisation . . . for psychotropic medications’ (Verdoux & Begaud, 2004). ́ Using the Drug Report of the German Public Health Insurance (Schwabe & Pfaffrath...
متن کاملUtilisation of psychotropic medications
The timely article by Verdoux & Begaud ́ hopefully begins to redress the imbalance between randomised controlled trials and other ways of evaluating drug treatments. I would like to present further evidence for the ‘gap between guidelines and utilisation . . . for psychotropic medications’ (Verdoux & Begaud, 2004). ́ Using the Drug Report of the German Public Health Insurance (Schwabe & Pfaffrath...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neuropsychopharmacology
سال: 2017
ISSN: 0893-133X,1740-634X
DOI: 10.1038/npp.2017.33